Cargando…
The Fucosylation Inhibitor, 2-Fluorofucose, Inhibits Vaso-Occlusion, Leukocyte-Endothelium Interactions and NF-ĸB Activation in Transgenic Sickle Mice
2-Fluorofucose (2FF) blocks the fucosylation and the tethering of sialyl-Lewis(x) tetrasaccharide and structural variants on leukocytes and red blood cells to P- and E-selectins on activated endothelial cell surfaces. Because P- and E-selectin are required for vaso-occlusion in murine sickle cell di...
Autores principales: | Belcher, John D., Chen, Chunsheng, Nguyen, Julia, Abdulla, Fuad, Nguyen, Phong, Nguyen, Minh, Okeley, Nicole M., Benjamin, Dennis R., Senter, Peter D., Vercellotti, Gregory M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338063/ https://www.ncbi.nlm.nih.gov/pubmed/25706118 http://dx.doi.org/10.1371/journal.pone.0117772 |
Ejemplares similares
-
Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction
por: Belcher, John D., et al.
Publicado: (2018) -
Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia
por: Belcher, John D., et al.
Publicado: (2018) -
Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease
por: Beckman, Joan D., et al.
Publicado: (2021) -
The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
por: Belcher, John D., et al.
Publicado: (2023) -
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease
por: McArthur, James G., et al.
Publicado: (2020)